Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABP-450 for Migraine Prevention
NCT04845178Phase 2Completed
- Sponsor
- AEON Biopharma, Inc.
- Start
- Mar 2021
- Primary completion
- Jun 2024
- Modality
- Bacterial Toxin Conjugates
- Countries
- 3
01
Overview
A Phase 2 trial of prabotulinumtoxinA in migraine, sponsored by AEON Biopharma, Inc.. Started Mar 2021; status: completed.
02
Drugs
prabotulinumtoxinA
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04845178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04845178.